-
Price Momentum
NVAX is trading near the top of its 52-week range and above its 200-day simple moving average.
-
Price change
The price of NVAX shares has increased $0.22 since the market last closed. This is a 2.14% rise.
-
Opened at $10.45.
The stock opened $0.15 higher than its previous close.
Key terms
About NVAX
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
-
Market cap: $1.68B
A market capitalization between $300 million and $2 billion places NVAX in the small capitalization category.
Key terms
Smart score
Latest NVAX news
NVAX Financials
-
Total revenue: $1.12B (1Y), $147.14M (Q4)
Total Revenue increased 64.69% since last year and increased 108.87% since last quarter.
-
Net income: $440.30M (1Y), $17.53M (Q4)
Net Income increased 334.83% since last year and held flat since last quarter.
-
Earnings per share: $2.54 (1Y), $0.11 (Q4)
EPS increased 306.46% since last year and held flat since last quarter.
Key terms
NVAX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVAX Competitors
-
How competitors are chosen
NVAX's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $1.68B
A market capitalization between $300 million and $2 billion places NVAX in the small capitalization category.
Key terms
Latest investing news
-
The Iran war threatens to undermine Trump’s favorite bragging point -
Stocks fall and global oil reclaims $100 as Iran’s new supreme leader vows to keep Strait of Hormuz closed -
Stocks rebound and oil whipsaws after briefly smashing through $100 per barrel -
Dow suffers worst week since April as oil hits $90 and weak jobs data adds to market anxiety


